Universe Pharmaceuticals Inc.

UPCNASDAQHealthcare● Active

$3.24

$-0.01(-0.31%)

Market Cap$1825159

P/E Ratio—

52W High$11

52W Low$2

Avg Volume20K

Open$3.11

Beta1.60

Free Cash Flow Financials Revenue

Universe Pharmaceuticals Inc. (UPC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

UPC · free cash flow · updated Jun 15, 2026

Core FCF metrics

UPC · FCF · TTM · margin & CAGR

Free cash flow was −$5.4M for FY2025 (fiscal year ending 2025-09-30), up 45.3% year-over-year The FCF margin was -30.2%.

FY2025 Free Cash Flow−$5.4M▲ +45.3% YoY

Trailing 12M (TTM)−$15.2Mtrailing 4 quarters sum

FCF Margin-30.2%−$5.4M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

UPC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$5.1M(0M)−$5.4M▲ +45.3%-30.2%

FY2024−$9.5M(0M)−$9.9M▼ 1017.3%-42.9%

FY2023$1.1M(0M)$1.1M▲ +176.5%3.3%

FY2022−$1.3M(0M)−$1.4M▲ +91.0%-3.5%

FY2021−$2.1M(14M)−$15.6M▼ 357.1%-32.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

UPC · P/FCF · FCF yield · FCF per share

Universe Pharmaceuticals Inc. (UPC) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-09-30

Cash flow statement summary

UPC · cash flow statement · operating / investing / financing

For FY2025, Universe Pharmaceuticals Inc. generated −$5.1M in operating cash flow and spent 0M in capital expenditures, yielding −$5.4M in free cash flow.

Operating Activities

−$5.1M

Cash from core business operations

2025-09-30

Investing Activities

−$0.3M

CapEx, acquisitions & investments

2025-09-30

Financing Activities

+$9.7M

Buybacks, dividends & debt

2025-09-30

FCF FormulaOperating CF (−$5.1M) − |CapEx| (0M) = FCF (−$5.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

UPC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Universe Pharmaceuticals Inc.YOU

UPC

−$5.4M+45.3%-30.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Universe Pharmaceuticals Inc. (UPC) reported free cash flow of −$5.4M for FY2025 (fiscal year ending 2025-09-30), up 45.3% year-over-year. The FCF margin was -30.2%.

Based on available data, Universe Pharmaceuticals Inc. has maintained positive free cash flow for at least 4 fiscal year(s). FCF peaked at $13.1M in FY2019.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

UPC free cash flow · 8 questions

Universe Pharmaceuticals Inc. free cash flow was −$5.4M for FY2025, up 45.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$15.2M.

UPC free cash flowUPC FCFUPC FCF 2025UPC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Universe Pharmaceuticals Inc. · Universe Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026